Examples of using Multi-center in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
The Salmeterol Multi-center Asthma Research Trial SMART.
Particularly for Phase III the following applies to most projects: randomized,double-blind, multi-center.
The question"mono- versus multi-center" however, has been recently discussed more frequently.
The safety andefficacy of the Zevalin therapeutic regimen were evaluated in two multi-center trials enrolling a total of 197 subjects.
Participation in multi-center studies in the field of pharmacotherapy and deep brain stimulation.
Investigator-initiated, prospective, randomized, open-label, multi-center trial with two parallel groups.
Additional multi-center studies followed, and in the year 2000 CE certification for the medial implant followed.
Conclusions: Using very well defined phenotypic criteria,a collection of families with AAU has been identified in this multi-center study.
The multi-center, randomized, double-blind, intra-individual study includes 50 patients at six study sites in Germany.
As businesses continue to develop, problems triggered by multi-center construction and centralized architecture have become more prevalent.
Fifty-three paediatric patients aged 2 to< 18 years were treated with voriconazole intwo prospective, open- label, non-comparative, multi-center clinical trials.
N\nThe TRUST study was a prospective, randomized, multi-center clinical trial that enrolled 1,450 patients at 102 North American sites.
A multi-center, randomized, placebo-controlled, double-blind study for investigation of the hypothesis that Sunphenon EGCG can improve cognitive performance in patients with Huntington's chorea.
MOR202 is currently in a phase 1/2a, open-label, multi-center, dose-escalation clinical study conducted in several sites in Germany and Austria.
The program focuses on the translation of basicresearch into clinical practice(bench to bedside) through national and international multi-center studies developing novel, targeted therapies.
The Phase 2a SECURE study was a prospective, multi-center, randomized, double-blind placebo-controlled trial evaluating SB012 in patients with moderate to severe ulcerative colitis.
The safety and efficacy of IMBRUVICA in patients with relapsed orrefractory MCL were evaluated in a single open-label, multi-center phase 2 study(PCYC-1104-CA) of 111 patients.
This multi-center study will last approximately 2 years from the date when the first patient starts until the last of the 140 participants receives their last dose of Rituximab.
About the GRID resultsGRID was a randomized, double-blind,placebo-controlled, multi-center, cross-over Phase III study of regorafenib for the treatment of GIST.
The efficacy of subcutaneous administered tocilizumab in alleviating the signs and symptoms of RA and radiographic response, was assessed in two randomised, double-blind,controlled, multi-center studies.
The safety and efficacy of Respreeza was evaluated in a randomized, double-blind, placebo- controlled, multi-center study(RAPID) followed by a 2-year open-label extension study RAPID extension study.
Data from a large clinical trial(the Salmeterol Multi-Center Asthma Research Trial, SMART) suggested African-American patients were at increased risk of serious respiratory-related events or deaths when using salmeterol compared with placebo see section 5.1.
The safety and efficacy of IMBRUVICA in WM(IgM-excreting lymphoplasmacytic lymphoma)were evaluated in an open-label, multi-center, single-arm trial of 63 previously treated patients.
The multi-center, single-arm, open-label study examines domatinostat(formerly 4SC-202) plus checkpoint inhibitor avelumab in up to 70 patients with advanced gastrointestinal cancer- precisely microsatellite-stable esophago-gastric and colorectal(MSS-GI) cancer.
The efficacy of venlafaxine prolonged-release capsules as a treatment for panic disorder was established in two double-blind,12-week, multi-center, placebo-controlled studies in adult outpatients with panic disorder, with or without agoraphobia.
A multi-center, randomized double-blind study comparing cabozantinib(N 219) with placebo(N 111) was conducted in patients with unresectable locally advanced or metastatic MTC and documented radiographic disease progression within 14 months prior to study entry.
The efficacy of venlafaxine prolonged-release capsules as a treatment for social anxiety disorder wasestablished in four double-blind, parallel-group, 12-week, multi-center, placebo-controlled, flexible-dose studies and one double-blind, parallel-group, 6-month, placebo-controlled, fixed/ flexible-dose study in adult outpatients.
Month results from the prospective, multi-center, 4EVER study were backed up by 12-month results from the multi-center, prospective PEACE registry, both of which shows Pulsar stent efficacy comparing very favorably with other bare metal stent study results.
The Phase II study is conducted as a randomized, double-blind, placebo-controlled, multi-center study evaluating the combination of resminostat and S-1 chemotherapy versus S-1 chemotherapy plus placebo as second-line treatment in 100 Japanese patients with unresectable or recurrent biliary tract cancer.
In a multi-center, randomized, double-blind, placebo-controlled 12-week clinical trial in 628 patients with high cholesterol, the co-administration of atorvastatin(10 mg, 20 mg, 40 mg, 80 mg) with ZETIA® 10mg lowered LDL"bad" cholesterol by an average of 53 to 61 percent from baseline across the dosing range compared to average LDL cholesterol reductions of 37 to 54 percent with atorvastatin alone.